252 related articles for article (PubMed ID: 22508938)
1. Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.
Sathyanarayana P; Dev A; Pradeep A; Ufkin M; Licht JD; Wojchowski DM
Blood; 2012 Jun; 119(23):5522-31. PubMed ID: 22508938
[TBL] [Abstract][Full Text] [Related]
2. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
3. RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development.
Verma R; Su S; McCrann DJ; Green JM; Leu K; Young PR; Schatz PJ; Silva JC; Stokes MP; Wojchowski DM
J Exp Med; 2014 Aug; 211(9):1715-22. PubMed ID: 25092874
[TBL] [Abstract][Full Text] [Related]
4. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
[TBL] [Abstract][Full Text] [Related]
5. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.
Menon MP; Karur V; Bogacheva O; Bogachev O; Cuetara B; Wojchowski DM
J Clin Invest; 2006 Mar; 116(3):683-94. PubMed ID: 16511603
[TBL] [Abstract][Full Text] [Related]
6. Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.
Singh S; Dev A; Verma R; Pradeep A; Sathyanarayana P; Green JM; Narayanan A; Wojchowski DM
PLoS One; 2012; 7(7):e38530. PubMed ID: 22808010
[TBL] [Abstract][Full Text] [Related]
7. Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells.
Li K; Menon MP; Karur VG; Hegde S; Wojchowski DM
Blood; 2003 Nov; 102(9):3147-53. PubMed ID: 12869513
[TBL] [Abstract][Full Text] [Related]
8. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution.
Halupa A; Bailey ML; Huang K; Iscove NN; Levy DE; Barber DL
Blood; 2005 Jan; 105(2):552-61. PubMed ID: 15213094
[TBL] [Abstract][Full Text] [Related]
9. Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling.
Slavova-Azmanova NS; Kucera N; Satiaputra J; Stone L; Magno A; Maxwell MJ; Quilici C; Erber W; Klinken SP; Hibbs ML; Ingley E
Blood; 2013 Jul; 122(2):262-71. PubMed ID: 23692855
[TBL] [Abstract][Full Text] [Related]
10. Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2(-/-) hematopoietic progenitors.
Ghaffari S; Kitidis C; Fleming MD; Neubauer H; Pfeffer K; Lodish HF
Blood; 2001 Nov; 98(10):2948-57. PubMed ID: 11698276
[TBL] [Abstract][Full Text] [Related]
11. Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.
Fukumoto T; Kubota Y; Kitanaka A; Yamaoka G; Ohara-Waki F; Imataki O; Ohnishi H; Ishida T; Tanaka T
Cell Signal; 2009 Dec; 21(12):1775-83. PubMed ID: 19665053
[TBL] [Abstract][Full Text] [Related]
12. Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.
Grebien F; Kerenyi MA; Kovacic B; Kolbe T; Becker V; Dolznig H; Pfeffer K; Klingmüller U; Müller M; Beug H; Müllner EW; Moriggl R
Blood; 2008 May; 111(9):4511-22. PubMed ID: 18239084
[TBL] [Abstract][Full Text] [Related]
13. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor.
Miura Y; Miura O; Ihle JN; Aoki N
J Biol Chem; 1994 Nov; 269(47):29962-9. PubMed ID: 7961995
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
[TBL] [Abstract][Full Text] [Related]
15. The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis.
Guihard S; Clay D; Cocault L; Saulnier N; Opolon P; Souyri M; Pagès G; Pouysségur J; Porteu F; Gaudry M
Blood; 2010 May; 115(18):3686-94. PubMed ID: 20223923
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins.
Dev A; Byrne SM; Verma R; Ashton-Rickardt PG; Wojchowski DM
J Exp Med; 2013 Feb; 210(2):225-32. PubMed ID: 23319700
[TBL] [Abstract][Full Text] [Related]
17. Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis.
Held MA; Greenfest-Allen E; Jachimowicz E; Stoeckert CJ; Stokes MP; Wood AW; Wojchowski DM
Exp Hematol; 2020 Apr; 84():29-44. PubMed ID: 32259549
[TBL] [Abstract][Full Text] [Related]
18. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Handoko A; Singer P; Stone L; McCarthy DJ; Klinken SP; Hibbs ML; Ingley E
Biochem J; 2014 May; 459(3):455-66. PubMed ID: 24552351
[TBL] [Abstract][Full Text] [Related]
19. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
Shi J; Yuan B; Hu W; Lodish H
Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
[TBL] [Abstract][Full Text] [Related]
20. EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis.
Hidalgo D; Bejder J; Pop R; Gellatly K; Hwang Y; Maxwell Scalf S; Eastman AE; Chen JJ; Zhu LJ; Heuberger JAAC; Guo S; Koury MJ; Nordsborg NB; Socolovsky M
Nat Commun; 2021 Dec; 12(1):7334. PubMed ID: 34921133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
